Serotonin–dopamine interaction: electrophysiological evidence
Abstract
In this review, the most relevant data regarding serotonin (5-hydroxytryptamine, 5-HT)/dopamine (DA) interaction in the brain, as studied by both in vivo and in vitro electrophysiological methods, are reported and discussed. The bulk of neuroanatomical data available clearly indicate that DA-containing neurons in the brain receive a prominent innervation from 5-HT originating in the raphe nuclei of the brainstem. Furthermore, this modulation seems to be reciprocal; DA neurons innervate the raphe nuclei and exert a tonic excitatory effect on them. Compelling electrophysiological data show that 5-HT can exert complex effects on the electrical activity of midbrain DA neurons mediated by the various receptor subtypes. The main control seems to be inhibitory, this effect being more marked in the ventral tegmental area (VTA) as compared to the substantia nigra pars compacta (SNc). In spite of a direct effect of 5-HT by its receptors located on DA cells, 5-HT can modulate their activity indirectly, modifying gamma-amino-n-butyric acid (GABA)-ergic and glutamatergic input to the VTA and SNc. Although 5-HT/DA interaction in the brain has been extensively studied, much work remains to be done to clarify this issue. The recent development of subtype-selective ligands for 5-HT receptors will not only allow a detailed understanding of this interaction but also lead to development of new treatment strategies, appropriate for those neuropsychiatric disorders in which an alteration of the 5-HT/DA balance is supposed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Serotonergic and dopaminergic markers are jointly present in their developmental origins, guidepost areas, as well as within the subdomains of the PFC, which is important for their intricate interaction later in life to establish higher cognitive functions.
“Serotonergic and dopaminergic markers are jointly present in their developmental origins, guidepost areas, as well as within the subdomains of the PFC, which is important for their intricate interaction later in life to establish higher cognitive functions [209, 232–234].”
From Development of prefrontal cortex (2022) · cites this paper as [233]
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,150 · see citing works
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 2,997 · see citing works
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415 · see citing works
Azmitia, E. C., & Segal, M. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,908 · see citing works
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,869 · see citing works
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · see citing works
Evidence for the existence of monoamine neurons in the central nervous system
Fuxé, K. (1965) · Cell and Tissue Research · doi:10.1007/bf00337069 · Cited by 1,567 · see citing works
Fuxé, K. (1965) · PubMed · Cited by 1,544 · see citing works
The control of firing pattern in nigral dopamine neurons: burst firing
Grace, A., & Bunney, B. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-11-02877.1984 · Cited by 1,346 · see citing works
Efferent connections of the substantia nigra and ventral tegmental area in the rat
Beckstead, R. M., Domesick, V. B., & Nauta, W. J. H. (1979) · Brain Research · doi:10.1016/0006-8993(79)91001-1 · Cited by 1,293 · see citing works
DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
Bunney, B. S., Walters, J. R., Roth, R. H., & Aghajanian, G. K. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283 · see citing works
Svensson, T. H., Bunney, B. S., & Aghajanian, G. K. (1975) · Brain Research · doi:10.1016/0006-8993(75)90276-0 · Cited by 1,009 · see citing works
Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 937 · see citing works
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 870 · see citing works
Uniform Inhibition of Dopamine Neurons in the Ventral Tegmental Area by Aversive Stimuli
Ungless, M. A., Magill, P. J., & Bolam, J. P. (2004) · Science · doi:10.1126/science.1093360 · Cited by 782 · see citing works
Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
Pazos, Á., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 684 · see citing works
Molecular biology of 5-HT receptors
Boess, F., & Martin, I. L. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90059-0 · Cited by 675 · see citing works
Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain
Wright, D. E., Seroogy, K. B., Lundgren, K. H., Davis, B. M., & Jennes, L. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903510304 · Cited by 548 · see citing works
Aghajanian, G. K., & Bunney, B. S. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508803 · Cited by 548 · see citing works
Margolis, E. B., Lock, H., Hjelmstad, G. O., & Fields, H. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.117069 · Cited by 527 · see citing works
Mansour, A., Meador‐Woodruff, J. H., Bunzow, J., Civelli, O., Akil, H., & Watson, S. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-08-02587.1990 · Cited by 467 · see citing works
Bunney, B. S., Aghajanian, G. K., & Roth, R. H. (1973) · Nature New Biology · doi:10.1038/newbio245123a0 · Cited by 434 · see citing works
Serotonin content of the brain stem nuclei in the rat
Palkovits, M., Brownstein, M., & Saavedra, J. M. (1974) · Brain Research · doi:10.1016/0006-8993(74)90688-x · Cited by 384 · see citing works
Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS
Clemett, D. A., Punhani, T., Duxon, M. S., Blackburn, T. P., & Fone, K. C. F. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00086-6 · Cited by 373 · see citing works
Hervé, D., Pickel, V. M., JOH, T. H., & Beaudet, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91588-5 · Cited by 372 · see citing works
Bruinvels, A. T., Landwehrmeyer, G. B., Gustafson, E. L., Durkin, M. M., Mengod, G., Branchek, T. A., Hoyer, D., & Palacios, J. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90067-1 · Cited by 350 · see citing works
κ opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
Margolis, E. B., Lock, H., Chefer, V. I., Shippenberg, T. S., Hjelmstad, G. O., & Fields, H. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511159103 · Cited by 326 · see citing works
Grace, A. A., & Bunney, B. S. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24386-5 · Cited by 315 · see citing works
Receptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclature
Martin, G. R., & Humphrey, P. P. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90058-2 · Cited by 305 · see citing works
Guiard, B. P., Mansari, M. E., Merali, Z., & Blier, P. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008383 · Cited by 302 · see citing works
Hoyer, D., Pazos, Á., Probst, A., & Palacios, J. M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90903-0 · Cited by 291 · see citing works
Díaz-Mataix, L., Scorza, M. C., Bortolozzi, A. A., Tóth, M., Celada, P., & Artigas, F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2999-05.2005 · Cited by 288 · see citing works
Evidence for the existence of a raphe projection to the substantia nigra in rat
Dray, A., Gonye, T. J., Oakley, N. R., & Tanner, T. (1976) · Brain Research · doi:10.1016/0006-8993(76)90005-6 · Cited by 284 · see citing works
Ugedo, L., Grenhoff, J., & Svensson, T. H. (1989) · Psychopharmacology · doi:10.1007/bf00442004 · Cited by 267 · see citing works
Sorensen, S. M., Kehne, J. H., Fadayel, G. M., Humphreys, T. M., Ketteler, H., Sullivan, C. K., Taylor, V. L., & Schmidt, C. J. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38366-7 · Cited by 258 · see citing works
Matteo, V. D., Giovanni, G. D., Mascio, M. D., & Esposito, E. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00047-7 · Cited by 251 · see citing works
Self-citation5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons
Johnson, S., Mercuri, N. B., & North, R. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-02000.1992 · Cited by 249 · see citing works
Abramowski, D., Rigo, M., Duc, D., Hoyer, D., & Staufenbiel, M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00138-7 · Cited by 243 · see citing works
Grace, A. A., & Bunney, B. S. (1980) · Science · doi:10.1126/science.7433992 · Cited by 241 · see citing works
Mengod, G., Pompeiano, M., ́nez-Mir, M. I. M., & Palacios, J. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90502-3 · Cited by 240 · see citing works
Lavoie, B. A., & Parent, A. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902990102 · Cited by 239 · see citing works
Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90136-7 · Cited by 235 · see citing works
Chiodo, L. A. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80073-3 · Cited by 233 · see citing works
Role of 5-HT2C receptors in the control of central dopamine function
Matteo, V. D., Blasi, A. D., Giulio, C. D., & Esposito, E. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01688-6 · Cited by 233 · see citing works
Self-citationD3 dopamine receptor mRNA is widely expressed in the human brain
Suzuki, M., Hurd, Y. L., Sokoloff, P., Schwartz, J.-C., & Sedvall, G. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01078-0 · Cited by 232 · see citing works
Morilak, D. A., Garlow, S. J., & Ciaranello, R. D. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90241-7 · Cited by 231 · see citing works
Sakai, K., Salvert, D., Touret, M., & Jouvet, M. (1977) · Brain Research · doi:10.1016/0006-8993(77)91010-1 · Cited by 226 · see citing works
Mengod, G., Nguyen, H., Le, H., Waeber, C., Lübbert, H., & Palacios, J. M. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90330-7 · Cited by 226 · see citing works
Fahn, S., Libsch, L. R., & Cutler, R. W. P. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90178-x · Cited by 224 · see citing works
Porras, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00333-5 · Cited by 222 · see citing works
Sari, Y., Miquel, M., Brisorgueil, M., Ruiz, G., Doucet, E., Hamon, M., & Vergé, D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00256-5 · Cited by 222 · see citing works
Felder, C. C., Kanterman, R. Y., Ma, A. L., & Axelrod, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2187 · Cited by 220 · see citing works
Giovanni, G. D., Deurwaerdère, P. D., Mascio, M. D., Matteo, V. D., Esposito, E., & Spampinato, U. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00655-1 · Cited by 219 · see citing works
Self-citationPrisco, S., Pagannone, S., & Esposito, E. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22843-9 · Cited by 214 · see citing works
Self-citationFibiger, H. C., & Miller, J. J. (1977) · Neuroscience · doi:10.1016/0306-4522(77)90120-8 · Cited by 213 · see citing works
Duxon, M. S., Flanigan, T. P., Reavley, A. C., Baxter, G. S., Blackburn, T. P., & Fone, K. C. F. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00480-0 · Cited by 210 · see citing works
Dray, A., Davies, J. I., Oakley, N. R., Tongroach, P., & Vellucci, S. V. (1978) · Brain Research · doi:10.1016/0006-8993(78)91077-6 · Cited by 209 · see citing works
Chiodo, L. A., & Bunney, B. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02539.1985 · Cited by 196 · see citing works
Bockstaele, E. J. V., & Pickel, V. M. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903340408 · Cited by 196 · see citing works
Cocaine inhibits GABA release in the VTA through endogenous 5-HT
Cameron, D., & Williams, J. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-11-06763.1994 · Cited by 188 · see citing works
Matteo, V. D., Giovanni, G. D., Mascio, M. D., & Esposito, E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02246-0 · Cited by 184 · see citing works
Self-citationPrisco, S., & Esposito, E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16684.x · Cited by 181 · see citing works
Self-citationDoherty, M. D., & Pickel, V. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02062-x · Cited by 178 · see citing works
Sinton, C. M., & Fallon, S. L. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90380-9 · Cited by 174 · see citing works
Kelland, M. D., Freeman, A. S., & Chiodo, L. A. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13049-8 · Cited by 171 · see citing works
Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
Nocjar, C., Roth, B. L., & Pehek, E. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00593-0 · Cited by 169 · see citing works
Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra
Nedergaard, S., Bolam, J. P., & Greenfield, S. A. (1988) · Nature · doi:10.1038/333174a0 · Cited by 166 · see citing works
Arborelius, L., Chergui, K., Murase, S., Nomikos, G. G., H��k, B. B., Chouvet, G., Hacksell, U., & Svensson, T. H. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165384 · Cited by 165 · see citing works
A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids
Cameron, D., Wessendorf, M. W., & Williams, J. T. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00444-7 · Cited by 163 · see citing works
Distribution of serotonin 5-HT2C receptors in the ventral tegmental area
Bubar, M. J., & Cunningham, K. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.071 · Cited by 162 · see citing works
Liu, S., Bubar, M. J., Lanfranco, M. F., Hillman, G. R., & Cunningham, K. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.064 · Cited by 157 · see citing works
Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade
Cremers, T. I. F. H., Giorgetti, M., Bosker, F. J., Hogg, S., Arnt, J., Mørk, A., Honig, G., Bøgesø, K.-P., Westerink, B. H. C., den Boer, H., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300474 · Cited by 157 · see citing works
Ji, S., Zhang, Y., Cleemput, J. V., Jiang, W., Liao, M., Li, L., Wan, Q., Backstrom, J. R., & Zhang, X. (2006) · Nature Medicine · doi:10.1038/nm1349 · Cited by 156 · see citing works
Pasqualetti, M., Ori, M., Castagna, M., Marazziti, D., Cassano, G. B., & Nardi, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00011-1 · Cited by 154 · see citing works
Moukhles, H., Bosler, O., Bolam, J. P., Vallée, A., Umbriaco, D., Geffard, M., & Doucet, G. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00452-6 · Cited by 151 · see citing works
Lacroix, L. P., Dawson, L. A., Hagan, J. J., & Heidbreder, C. A. (2003) · Synapse · doi:10.1002/syn.10288 · Cited by 146 · see citing works
Marquis, K. L., Sabb, A. L., Logue, S. F., Brennan, J. A., Piesla, M. J., Comery, T. A., Grauer, S. M., Ashby, C. R., Nguyen, H. Q., Dawson, L. A., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106989 · Cited by 145 · see citing works
Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro
Pessia, M., Jiang, Z., North, R. A., & Johnson, S. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90495-2 · Cited by 138 · see citing works
Barnes, J. M., Barnes, N. M., Champaneria, S., Costall, B., & Naylor, R. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90110-d · Cited by 131 · see citing works
Bockstaele, E. J. V., Cestari, D. M., & Pickel, V. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91330-7 · Cited by 126 · see citing works
Giovanni, G. D., Matteo, V. D., Grutta, V. L., & Esposito, E. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00561-3 · Cited by 125 · see citing works
Self-citationPhysiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors
Berg, K. A., Harvey, J. A., Spampinato, U., & Clarke, W. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.008 · Cited by 111 · see citing works
Gervais, J., & Rouillard, C. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4 · Cited by 109 · see citing works
Jones, S., & Kauer, J. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09780.1999 · Cited by 102 · see citing works
Distribution of serotonin and synthesizing enzymes in discrete areas of the brain.
Saavedra, J. M. (1977) · PubMed · Cited by 102 · see citing works
Ultrastructure and synaptic targets of the raphe-nigral projection in the rat
Corvaja, N., Doucet, G., & Bolam, J. P. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90510-m · Cited by 101 · see citing works
REGIONAL DISTRIBUTION OF MONOAMINES AND THEIR METABOLITES IN THE HUMAN BRAIN
Mackay, A. V. P., Yates, C. M., Wright, A., Hamilton, P., & Davies, P. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb10792.x · Cited by 98 · see citing works
Aman, T. K., Shen, R., & Haj‐Dahmane, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111690 · Cited by 96 · see citing works
Invernizzi, R. W., Pierucci, M., Calcagno, E., Giovanni, G. D., Matteo, V. D., Benigno, A., & Esposito, E. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.004 · Cited by 95 · see citing works
Self-citationSa√±udo-Pe√±a, M. C., Force, M., Tsou, K., Miller, A. S., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2 · Cited by 93 · see citing works
Andersson, J. L., Nomikos, G. G., Marcus, M. M., Hertel, P., Mathé, J. M., & Svensson, T. H. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00172774 · Cited by 92 · see citing works
Sorensen, S. M., Humphreys, T. M., & Palfreyman, M. G. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90402-0 · Cited by 92 · see citing works
Brodie, M. S., Trifunovic, R., & Shefner, S. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09580-1 · Cited by 89 · see citing works
Ferré, S., & Artigas, F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02187.x · Cited by 87 · see citing works
Waeber, C., & PALACIOS, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90082-1 · Cited by 85 · see citing works
Central Serotonin2C Receptor: From Physiology to Pathology
Giovanni, G. D., Matteo, V. D., Pierucci, M., Benigno, A., & Esposito, E. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778522113 · Cited by 85 · see citing works
Self-citationD2‐like dopamine receptor activation excites rat dorsal raphe 5‐HT neurons in vitro
Haj‐Dahmane, S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01616.x · Cited by 85 · see citing works
Boegman, R. J., & Vincent, S. R. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199601)22:1 · Cited by 84 · see citing works
Augmentation of SSRI Effects on Serotonin by 5-HT2C Antagonists: Mechanistic Studies
Cremers, T. I. F. H., Rea, K., Bosker, F. J., Wikström, H., Hogg, S., Mørk, A., & Westerink, B. H. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301287 · Cited by 83 · see citing works
Kal�n, P., Skagerberg, G., & Lindvall, O. (1988) · Experimental Brain Research · doi:10.1007/bf00279662 · Cited by 81 · see citing works
Distribution of dopamine-immunoreactive fibers in the rat brainstem
Kitahama, K., Nagatsu, I., Geffard, M., & Maeda, T. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00047-2 · Cited by 79 · see citing works
Ascending afferent regulation of rat midbrain dopamine neurons
Kelland, M. D., Freeman, A. S., Rubin, J. R., & Chiodo, L. A. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90121-q · Cited by 77 · see citing works
Ventral pallidostriatal pathway in the monkey: Evidence for modulation of basal ganglia circuits
Spooren, W. P. J. M., Lynd‐Balta, E., Mitchell, S., & Haber, S. N. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960701)370:3 · Cited by 76 · see citing works
Maj, J., & Moryl, E. (1992) · Journal of Neural Transmission · doi:10.1007/bf01244819 · Cited by 73 · see citing works
Martín‐Ruiz, R., Ugedo, L., Honrubia, M., Mengod, G., & Artigas, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00275.x · Cited by 72 · see citing works
Liu, Z., Bunney, E. B., Appel, S. B., & Brodie, M. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00281.2003 · Cited by 70 · see citing works
Boothman, L. J., Mitchell, S. N., & Sharp, T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.020 · Cited by 67 · see citing works
Trent, F., & Tepper, J. M. (1991) · Experimental Brain Research · doi:10.1007/bf00230974 · Cited by 65 · see citing works
Mori, S., Matsuura, T., Takino, T., & Sano, Y. (1987) · Anatomy and Embryology · doi:10.1007/bf00309747 · Cited by 65 · see citing works
Doherty, M. D., & Pickel, V. M. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1147 · Cited by 63 · see citing works
Milner, T. A., Shah, P., & Pierce, J. P. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3 · Cited by 60 · see citing works
Rasmussen, K., Stockton, M. E., & Czachura, J. F. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90781-k · Cited by 58 · see citing works
Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration
Ikemoto, K., Nishimura, A., Okado, N., Mikuni, M., Nishi, K., & Nagatsu, I. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02237-4 · Cited by 56 · see citing works
Lucas, G., Matteo, V. D., Deurwaerdère, P. D., Porras, G., Martín‐Ruiz, R., Artigas, F., Esposito, E., & Spampinato, U. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01453.x · Cited by 55 · see citing works
Self-citationPublisher, B. S. P. B. S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778521805 · Cited by 54 · see citing works
Pierucci, M., Matteo, V. D., & Esposito, E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062208 · Cited by 52 · see citing works
Self-citationSerotonin‐1B receptor‐mediated inhibition of [3H]GABA release from rat ventral tegmental area slices
Yan, Q., & Yan, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00643.x · Cited by 50 · see citing works
Porras, G., Matteo, V. D., Deurwaerdère, P. D., Esposito, E., & Spampinato, U. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00212-5 · Cited by 50 · see citing works
Self-citationSekine, Y., Suzuki, K., Ramachandran, P. V., Blackburn, T. P., & Ashby, C. R. (2007) · Synapse · doi:10.1002/syn.20349 · Cited by 49 · see citing works
Wirtshafter, D., Stratford, T. R., & Asin, K. E. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90509-x · Cited by 48 · see citing works
Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro
Brodie, M. S., & Bunney, E. B. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.3.2077 · Cited by 46 · see citing works
Minabe, Y., Ashby, C. R., Schwartz, J. E., & Wang, R. Y. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90162-j · Cited by 45 · see citing works
Minabe, Y., Shirayama, Y., Hashimoto, K., Routledge, C. A., Hagan, J. J., & Ashby, C. R. (2004) · Synapse · doi:10.1002/syn.20002 · Cited by 44 · see citing works
Distribution and characterization of [3H]mesulergine binding in human brain postmortem
Marazziti, D., Rossi, A., Giannaccini, G., Zavaglia, K. M., Dell’Osso, L., Lucacchini, A., & Cassano, G. B. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00045-0 · Cited by 44 · see citing works
Olijslagers, J. E., Werkman, T. R., McCreary, A. C., Kruse, C. G., & Wadman, W. J. (2005) · Current Neuropharmacology · doi:10.2174/157015906775203020 · Cited by 42 · see citing works
Berretta, N., Freestone, P. S., Guatteo, E., de Castro, D., Geracitano, R., Bernardi, G., Mercuri, N. B., & Lipski, J. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.01.014 · Cited by 42 · see citing works
Slow Oscillatory Firing: A Major Firing Pattern of Dopamine Neurons in the Ventral Tegmental Area
Shi, W. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00317.2005 · Cited by 42 · see citing works
Comparison of projections of the dorsal and median raphe nuclei, with some functional considerations
Vertes, R. P., & Linley, S. B. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.046 · Cited by 39 · see citing works
Olijslagers, J. E., Werkman, T. R., McCreary, A. C., Siarey, R. J., Kruse, C. G., & Wadman, W. J. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.003 · Cited by 38 · see citing works
Bunney, E. B., Appel, S. B., & Brodie, M. S. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39246-8 · Cited by 38 · see citing works
5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system
Kilpatrick, G. J., Hagan, R. M., & Gale, J. D. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00063-0 · Cited by 37 · see citing works
Zacopride in Schizophrenia: A Single-blind Serotonin Type 3 Antagonist Trial
Faustman, W. O. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090079013 · Cited by 37 · see citing works
Decavel, C., Lescaudron, L., Mons, N. E., & Calas, A. (1987) · Journal of Histochemistry & Cytochemistry · doi:10.1177/35.11.3309046 · Cited by 35 · see citing works
Blackburn, T. P., Minabe, Y., Middlemiss, D. N., Shirayama, Y., Hashimoto, K., & Ashby, C. R. (2002) · Synapse · doi:10.1002/syn.10116 · Cited by 32 · see citing works
Shi, W. X., Nathaniel, P., & Bunney, B. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10609-5 · Cited by 31 · see citing works
Blier, P. U., de Montigny, C., & Azzaro, A. J. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508779 · Cited by 29 · see citing works
Ashby, C. R., Jiang, L. H., & Wang, R. Y. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90574-p · Cited by 28 · see citing works
Cameron, D., & Williams, J. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb01947.x · Cited by 28 · see citing works
Minabe, Y., Hashimoto, K., Watanabe, K., & Ashby, C. R. (2001) · Synapse · doi:10.1002/syn.1031 · Cited by 27 · see citing works
Prisco, S., Pessia, M., Ceci, A., Borsini, F., & Esposito, E. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90089-m · Cited by 25 · see citing works
Self-citationIntracellular 5-HT2C-receptor dephosphorylation: a new target for treating drug addiction
Müller, C. P., & Carey, R. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.003 · Cited by 25 · see citing works
Trifunovic, R., & Brodie, M. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12271-4 · Cited by 24 · see citing works
Mascio, M. D., & Esposito, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00108-5 · Cited by 23 · see citing works
Self-citationBrain monoamines in the rhesus monkey during long-term neuroleptic administration.
Shannak, K. S., & Hornykiewicz, O. (1980) · PubMed · Cited by 22 · see citing works
Paolucci, E., Berretta, N., Tozzi, A., Bernardi, G., & Mercuri, N. B. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03015.x · Cited by 20 · see citing works
Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
Giovanni, G. D. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708783885192 · Cited by 18 · see citing works
Zhang, Q.-J., Gao, R., Liu, J., Liu, Y.-P., & Wang, S. (2007) · PubMed · Cited by 17 · see citing works
Mnie‐Filali, O., Dahan, L., Zimmer, L., & Haddjeri, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.037 · Cited by 14 · see citing works
Electrodiffusion of synaptic receptors: a mechanism to modify synaptic efficacy?
Savtchenko, L. P., Коrogod, S. М., & Rusakov, D. A. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1 · Cited by 12 · see citing works
Self-citationChu, Y., Liu, J., Feng, J., Wang, Y., Zhang, Q.-J., & Li, Q. (2004) · PubMed · Cited by 10 · see citing works
Role of central 5-HT2C receptor in the control of basal ganglia functions
Esposito, E., Matteo, V. D., Pierucci, M., Benigno, A., & Giovanni, G. D. (2007) · OAR@UM (University of Malta) · Cited by 5 · see citing works
Self-citationCornea-Hébert (1999) · doi:10.1002/(sici)1096-9861(19990628)409:2
Flagged first, then by citations
Cited by
Sorted by citations
International society of sports nutrition position stand: caffeine and performance
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby, D., Stout, J., Graves, B. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-5 · Cited by 686 · see citing works
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665 · see citing works
Development of prefrontal cortex
Kolk, S. M., & Rakic, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01137-9 · Cited by 378 · see citing works
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT
Vermeire, S., Audenaert, K., Vandermeulen, E., Mees, R. D., van Bree, H., Dobbeleir, A. A., Peremans, K. Y., De, R., Declercq, A., Maes, S., et al. (2011) · Cited by 297 · see citing works
Hale, M. W., Shekhar, A., & Lowry, C. A. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9827-1 · Cited by 210 · see citing works
Wang, H.-L., Zhang, S., Qi, J., Wang, H., Cachope, R., Mejias-Aponte, C. A., Gomez, J. A., Mateo-Semidey, G. E., Beaudoin, G. M. J., Paladini, C. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.014 · Cited by 176 · see citing works
Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System
Peters, K. Z., Cheer, J. F., & Tonini, R. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.02.001 · Cited by 171 · see citing works
Deurwaerdère, P. D., & Giovanni, G. D. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.004 · Cited by 164 · see citing works
Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
Oades, R. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00926-6 · Cited by 169 · see citing works
Multiple Modes of Impulsivity in Parkinson's Disease
Nombela, C., Rittman, T., Robbins, T. W., & Rowe, J. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085747 · Cited by 131 · see citing works
Transcranial direct-current stimulation increases extracellular dopamine levels in the rat striatum
Tanaka, T., Takano, Y., Tanaka, S., Hironaka, N., Kobayashi, K., Hanakawa, T., Watanabe, K., & Honda, M. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00006 · Cited by 125 · see citing works
“The extracellular serotonin level in the striatum was also measured, as it is known to be associated with the dopamine level (Di Giovanni et al., 2008; Navailles and De Deurwaerdere, 2011).”
BackgroundParker, M. O., Brock, A. J., Walton, R. T., & Brennan, C. H. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00063 · Cited by 130 · see citing works
Early Life Stress, Depression And Parkinson’s Disease: A New Approach
Dallé, E., & Mabandla, M. V. (2018) · Molecular Brain · doi:10.1186/s13041-018-0356-9 · Cited by 124 · see citing works
Darmani, N. A., & Ray, A. P. (2009) · Chemical Reviews · doi:10.1021/cr900117p · Cited by 110 · see citing works
The role of the serotonergic system at the interface of aggression and suicide
Bortolato, M., Pivac, N., Šeler, D. M., Perković, M. N., Pessia, M., & Giovanni, G. D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.015 · Cited by 110 · see citing works
Baumann, M. H., Clark, R. D., Woolverton, W. L., Wee, S., Blough, B. E., & Rothman, R. B. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176271 · Cited by 110 · see citing works
Presynaptic control of serotonin on striatal dopamine function
Navailles, S., & Deurwaerdère, P. D. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2029-y · Cited by 109 · see citing works
Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
Chaudhuri, К. R., Rizos, A., & Sethi, K. D. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0981-5 · Cited by 104 · see citing works
Zheng, X., An, K., Dai, C., Liang, Y. L., Xie, T., Xie, L. Y., Peng, Y., Wang, G., & Hao, H. (2012) · Analytical Chemistry · doi:10.1021/ac3025202 · Cited by 104 · see citing works
A review of the role of serotonin system genes in obsessive-compulsive disorder
Sinopoli, V. M., Burton, C. L., Kronenberg, S., & Arnold, P. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.029 · Cited by 107 · see citing works
Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal
Kaufling, J., & Aston‐Jones, G. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0715-15.2015 · Cited by 89 · see citing works
Guiard, B. P., Mansari, M. E., & Blier, P. (2009) · Current Drug Targets · doi:10.2174/138945009789735156 · Cited by 94 · see citing works
Emotional dysfunction in Parkinson's disease.
Blonder, L. X., & Slevin, J. T. (2011) · PubMed Central · doi:10.3233/ben-2011-0329 · Cited by 83 · see citing works
Light-sensitive brain pathways and aging
Daneault, V., Dumont, M., Massé, É., Vandewalle, G., & Carrier, J. (2016) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-016-0091-9 · Cited by 83 · see citing works
Current animal models of obsessive compulsive disorder: an update
Albelda, N. S., & Joel, D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.070 · Cited by 81 · see citing works
Nikolic, K. M., Mavridis, L., Djikić, T., Vučićević, J., Agbaba, D. D., Yelekçi, K., & Mitchell, J. B. O. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00265 · Cited by 78 · see citing works
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures
Venzi, M., David, F., Bellet, J., Cavaccini, A., Bombardi, C., Crunelli, V., & Giovanni, G. D. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.016 · Cited by 72 · see citing works
Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
Polter, A. M., & Li, X. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00031 · Cited by 67 · see citing works
Polypharmacology of dopamine receptor ligands
Butini, S., Nikolic, K. M., Kassel, S., Brückmann, H., Filipić, S., Agbaba, D. D., Gemma, S., Brogi, S., Brindisi, M., Campiani, G., et al. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.011 · Cited by 67 · see citing works
Scheunemann, L., Plaçais, P.-Y., Dromard, Y., Schwärzel, M., & Préat, T. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.032 · Cited by 67 · see citing works
The Formation and Function of the VTA Dopamine System
Hou, G., Hao, M., Duan, J., & Han, M.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073875 · Cited by 65 · see citing works
Jaunarajs, K. L. E., George, J. A., & Bishop, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.052 · Cited by 65 · see citing works
The Engagement of Cytochrome P450 Enzymes in Tryptophan Metabolism
Haduch, A., Bromek, E., Kuban, W., & Daniel, W. A. (2023) · Metabolites · doi:10.3390/metabo13050629 · Cited by 63 · see citing works
Serotonin excites fast‐spiking interneurons in the striatum
Blomeley, C. P., & Bracci, E. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06725.x · Cited by 62 · see citing works
Aging Reduces the Stimulating Effect of Blue Light on Cognitive Brain Functions
Daneault, V., Hébert, M., Albouy, G., Doyon, J., Dumont, M., Carrier, J., & Vandewalle, G. (2014) · SLEEP · doi:10.5665/sleep.3314 · Cited by 59 · see citing works
Increased local dopamine secretion has growth‐promoting effects in cholangiocarcinoma
Coufal, M., Invernizzi, P., Gaudio, E., Bernuzzi, F., Frampton, G. A., Onori, P., Franchitto, A., Carpino, G., Ramirez, J. C., Alvaro, D., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24909 · Cited by 60 · see citing works
Schilman, E. A., Klavir, O., Winter, C., Sohr, R., & Joel, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.208 · Cited by 56 · see citing works
Delaville, C., Navailles, S., & Benazzouz, A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.024 · Cited by 55 · see citing works
Clark, P., Amat, J., McConnell, S. O., Ghasem, P. R., Greenwood, B. N., Maier, S. F., & Fleshner, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141898 · Cited by 53 · see citing works
Additive effects of serotonergic and dopaminergic polymorphisms on trait impulsivity
Varga, G., Székely, A., Antal, P., Sárközy, P., Nemoda, Z., Demetrovics, Z., & Sasvári‐Székely, M. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32025 · Cited by 52 · see citing works
A Review of Transcranial Magnetic Stimulation in Vascular Dementia
Pennisi, G., Ferri, R., Cantone, M., Lanza, G., Pennisi, M., Vinciguerra, L., Malaguarnera, G., & Bella, R. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000322798 · Cited by 51 · see citing works
Demireva, E. Y., Suri, D., Morelli, E., Mahadevia, D., Chuhma, N., Teixeira, C. M., Ziolkowski-Blake, A., Hersh, M. A., Fifer, J. E., Bagchi, S., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0227-x · Cited by 52 · see citing works
Orbán, G., Bombardi, C., Marino, A., Colangeli, R., Pierucci, M., Pomara, C., Pessia, M., Bucchieri, F., Benigno, A., Smolders, I. J., et al. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12285 · Cited by 46 · see citing works
Self-citationHaduch, A., & Daniel, W. A. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1554674 · Cited by 45 · see citing works
Restless legs syndrome: Over 50 years of E uropean contribution
Khachatryan, S. G., Ferri, R., Fulda, S., Garcı́a-Borreguero, D., Manconi, M., Muntean, M., & Stefani, A. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13632 · Cited by 41 · see citing works
Balasubramani, P. P., Chakravarthy, V. S., Ravindran, B., & Moustafa, A. A. (2014) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2014.00047 · Cited by 42 · see citing works
Haleem, D. J. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000123 · Cited by 41 · see citing works
Prinz, A., Selesnew, L.-M., Liss, B., Roeper, J., & Carlsson, T. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.06.015 · Cited by 38 · see citing works
The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap
Szechtman, H., Harvey, B. H., Woody, E. Z., & Hoffman, K. L. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017772 · Cited by 40 · see citing works
The dopaminergic system and Alzheimer’s disease
Zhang, Y., Liang, Y., & Gu, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00230 · Cited by 45 · see citing works
Karanges, E. A., Li, K. M., Motbey, C. P., Callaghan, P. D., Katsifis, A. G., & McGregor, I. S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100006x · Cited by 39 · see citing works
Haduch, A., Bromek, E., Kot, M., Kamińska, K., Gołembiowska, K., & Daniel, W. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13031 · Cited by 38 · see citing works
Melatonin Supports CYP2D-Mediated Serotonin Synthesis in the Brain
Haduch, A., Bromek, E., Wójcikowski, J., Gołembiowska, K., & Daniel, W. A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067413 · Cited by 36 · see citing works
Hoertel, N., Cipel, H., Blanco, C., Oquendo, M. A., Ellul, P., Leaune, É., Limosin, F., Peyre, H., & Costemale-Lacoste, J.-F. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.01.045 · Cited by 37 · see citing works
HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory
Drago, A., Alboni, S., Brunello, N., Ronchi, D. D., & Serretti, A. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0724-6 · Cited by 34 · see citing works
Katz, N., Guiard, B. P., Mansari, M. E., & Blier, P. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109348178 · Cited by 35 · see citing works
Association of Cigarette Smoking with Sleep Disturbance and Neurotransmitters in Cerebrospinal Fluid
Li, H., Liu, Y., Xing, L., Yang, X., Xu, J., Ren, Q., Su, K., Lu, Y., & Wang, F. (2020) · Nature and Science of Sleep · doi:10.2147/nss.s272883 · Cited by 36 · see citing works
Impact of Serotonin (5-HT)2C Receptors On Executive Control Processes
Pennanen, L., van der Hart, M., Yu, L., & Tecott, L. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.258 · Cited by 32 · see citing works
Sternat, T., Fotinos, K., Fine, A., Epstein, I., & Katzman, M. A. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s170645 · Cited by 31 · see citing works
Can 5-HT3 antagonists contribute toward the treatment of schizophrenia?
Ellenbroek, B. A., & Prinssen, E. P. M. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000102 · Cited by 29 · see citing works
Kreiss, D. S., & Deurwaerdère, P. D. (2017) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2017.05.007 · Cited by 28 · see citing works
Zhang, K., Lu, J., & Yao, L. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.11.004 · Cited by 27 · see citing works
Hall, F. S., Sora, I., Hen, R., & Uhl, G. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115009 · Cited by 26 · see citing works
Dombrovski, A. Y., Mulsant, B. H., Ferrell, R. E., Lotrich, F. E., Rosen, J., Wallace, M. J., Houck, P. R., Mazumdar, S., & Pollock, B. G. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328333ee10 · Cited by 25 · see citing works
Pierre, C., Pradère, N., Froc, C., Ornelas‐García, C. P., Callebert, J., & Rétaux, S. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.226092 · Cited by 25 · see citing works
Effect of paroxetine and bupropion on human resting brain perfusion: An arterial spin labeling study
Viviani, R., Abler, B., Seeringer, A., & Stingl, J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.014 · Cited by 25 · see citing works
Brownley, K. A., Boettiger, C. A., Young, L., & Cefalu, W. T. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.03.020 · Cited by 25 · see citing works
Fletcher, P. J., Sinyard, J., & Higgins, G. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.07.002 · Cited by 25 · see citing works
Melo-Felippe, F. B., Andrade, J. B. D. S., Giori, I. G., Vieira-Fonseca, T., Fontenelle, L. F., & Kohlrausch, F. B. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0697-0 · Cited by 26 · see citing works
Gendle, M. H., & Golding, A. C. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1139 · Cited by 24 · see citing works
Voigt, R. M., & Napier, T. C. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00092 · Cited by 23 · see citing works
Predicting targets of compounds against neurological diseases using cheminformatic methodology
Nikolic, K. M., Mavridis, L., Bautista‐Aguilera, Ó. M., Marco‐Contelles, J., Stark, H., Carreiras, M. C., Rossi, I., Massarelli, P., Agbaba, D. D., Ramsay, R. R., et al. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9816-1 · Cited by 22 · see citing works
Leg movements during sleep in children treated with serotonergic antidepressants
Ferri, R., Mogavero, M. P., Bruni, O., Picchietti, D. L., Kapoor, V., & DelRosso, L. M. (2021) · SLEEP · doi:10.1093/sleep/zsab236 · Cited by 22 · see citing works
Karanges, E. A., Kashem, M., Sarker, R., Ahmed, E. U., Ahmed, S., van Nieuwenhuijzen, P. V., Kemp, A., & McGregor, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00086 · Cited by 24 · see citing works
Bidirectional role of dopamine in learning and memory-active forgetting
Díaz, F. C., Caffino, L., & Fumagalli, F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.011 · Cited by 22 · see citing works
Direct serotonin release in humans shapes aversive learning and inhibition
Colwell, M., Tagomori, H., Shang, F., Cheng, H. I., Wigg, C., Browning, M. D., Cowen, P. J., Murphy, S. E., & Harmer, C. J. (2024) · Nature Communications · doi:10.1038/s41467-024-50394-x · Cited by 18 · see citing works
Understanding Anhedonia: The Role of Perceived Control
MacAulay, R., Mcgovern, J., & Cohen, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-8591-4_2 · Cited by 13 · see citing works
Acute Stress Exposure Alters Food-Related Brain Monoaminergic Profiles in a Rat Model of Anorexia
Reed, C. H., Bauer, E. E., Shoeman, A., Buhr, T. J., & Clark, P. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab298 · Cited by 19 · see citing works
Jukić, M. M., Carrillo‐Roa, T., Bar, M., Becker, G., Jovanovic, V. M., Zega, K., Binder, E. B., & Brodski, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.244 · Cited by 19 · see citing works
Effect of Caffeine on Endurance Performance in Athletes May Depend on HTR2A and CYP1A2 Genotypes
Guest, N. S., Corey, P., Tyrrell, P. N., & El‐Sohemy, A. (2020) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003665 · Cited by 19 · see citing works
Access to the CNS: Biomarker Strategies for Dopaminergic Treatments
van den Brink, W. J., Palić, S., Köhler, I., & de Lange, E. C. M. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2333-x · Cited by 17 · see citing works
Worhunsky, P. D., Angarita, G. A., Zhai, Z. W., Matuskey, D., Gallezot, J., Malison, R. T., Carson, R. E., & Potenza, M. N. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00874-7 · Cited by 17 · see citing works
Broadfoot, C. K., Lenell, C., Kelm‐Nelson, C. A., & Ciucci, M. R. (2022) · SSRN Electronic Journal · doi:10.1016/j.bbr.2022.114157 · Cited by 15 · see citing works
Antipsychotics and the Dopamine–Serotonin Connection
Ellenbroek, B., & Cesura, A. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_51 · Cited by 18 · see citing works
Zárate, R. V., Hidalgo, S., Navarro, N., Molina‐Mateo, D., Arancibia, D., Rojo-Cortés, F., Oliva, C., Andrés, M. E., Zamorano, P. L., & Campusano, J. M. (2022) · Cells · doi:10.3390/cells11091544 · Cited by 15 · see citing works
The h-Current in the Substantia Nigra pars Compacta Neurons: A Re-examination
Gambardella, C., Pignatelli, A., & Belluzzi, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052329 · Cited by 15 · see citing works
Antidepressants and Adolescent Brain Development
Karanges, E. A., & McGregor, I. S. (2011) · Future Neurology · doi:10.2217/fnl.11.51 · Cited by 15 · see citing works
Woody, E. Z., Hoffman, K. L., & Szechtman, H. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.04.003 · Cited by 16 · see citing works
Stępniowska, A., Drażbo, A. A., Kozłowski, K., Ognik, K., & Jankowski, J. (2019) · Animals · doi:10.3390/ani10010045 · Cited by 15 · see citing works
Imbalance between dopamine and serotonin caused by neonatal habenula lesion
Lee, Y., Kim, Y., Lee, J., Lee, S., & Goto, Y. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113316 · Cited by 14 · see citing works
Long-term administration of the antidepressant vilazodone modulates rat brain monoaminergic systems
Mansari, M. E., Crnic, A., Oosterhof, C. A., & Blier, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.007 · Cited by 14 · see citing works
Fletcher, P. J., Zeeb, F. D., Browne, C. J., Higgins, G. A., & Soko, A. D. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4529-5 · Cited by 14 · see citing works
Castle, M., & Flanigan, M. E. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100618 · Cited by 13 · see citing works
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson’s Disease
Marino, G., Campanelli, F., Natale, G., Carluccio, M. D., Servillo, F., Ghiglieri, V., & Calabresi, P. (2025) · Current Neuropharmacology · doi:10.2174/011570159x336597241217062042 · Cited by 13 · see citing works
Brela, M. Z., Prah, A., Boczar, M., Stare, J., & Mavri, J. (2019) · Molecules · doi:10.3390/molecules24234359 · Cited by 13 · see citing works
In Vivo Microdialysis in Parkinson’s Research
Giovanni, G. D., Esposito, E., & Matteo, V. D. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_18 · Cited by 12 · see citing works
Self-citationBoulougouris, V., Malogiannis, I. A., Lockwood, G., Zervas, I. M., & Giovanni, G. D. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3669-z · Cited by 11 · see citing works
Igari, M., Shen, H., Hagino, Y., Fukushima, S., Kasahara, Y., Lesch, K., Murphy, D. L., Hall, F. S., Uhl, G. R., Ikeda, K., et al. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000120 · Cited by 12 · see citing works
Quand la saison devient synonyme de dépression
Gagné, A.-M., Bouchard, G., Tremblay, P., Sasseville, A., & Hébert, M. (2010) · médecine/sciences · doi:10.1051/medsci/201026179 · Cited by 11 · see citing works
Deurwaerdère, P. D., Casarrubea, M., Cassar, D., Radic, M., Puginier, E., Chagraoui, A., Crescimanno, G., Crunelli, V., & Giovanni, G. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.886033 · Cited by 10 · see citing works
- Authors
- DIGIOVANNI, G., DIMATTEO, V, PIERUCCI, M., & ESPOSITO, E.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- ESPOSITO, E
- ORCID
- PIERUCCI, M
- Venue
- Progress in Brain Research
- Publisher
- Elsevier
- Published
- 2008
- Volume
- 172
- Pages
- 45-71
- ISSN
- 0079-6123 (ISSN-L)
- OpenAlex
- W1554279409
- Cited by
- 151
- References
- 153
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 10 · 2018: 7 · 2017: 5 · 2016: 10 · 2015: 9 · 2014: 15 · 2013: 10 · 2012: 10
- FWCI
- 12.85
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Progress in brain research (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- serotonin-dopamine interaction, serotonin, dopaminergic neurons, raphe nuclei, ventral tegmental area, substantia nigra pars compacta, serotonin receptors, GABAergic input, glutamatergic input, neuropsychiatric disorders, subtype-selective ligands
- MeSH terms
- Animals, Brain, Dopamine, Electric Stimulation, Electrophysiology, Neural Pathways, Neurons, Receptors, Serotonin, Serotonin, Serotonin Antagonists, Serotonin Receptor Agonists, Selective Serotonin Reuptake Inhibitors, Dopamine Agonists, Dopamine Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review